Bicycle Therapeutics (BCYC) Insider Trading & Ownership $9.16 +0.43 (+4.95%) As of 12:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bicycle Therapeutics (NASDAQ:BCYC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$21.23 MNumber OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$867,140.87 Get BCYC Insider Trade Alerts Want to know when executives and insiders are buying or selling Bicycle Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCYC Insider Buying and Selling by Quarter Remove Ads Bicycle Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/6/2025Travis Alvin ThompsonCAOSell2,686$15.00$40,290.00 1/2/2025Alethia YoungCFOSell1,395$14.09$19,655.55 1/2/2025Alistair MilnesCOOSell4,578$14.09$64,504.02 1/2/2025Kevin LeeCEOSell9,038$14.09$127,345.42 1/2/2025Michael SkynnerCTOSell3,287$14.09$46,313.83 1/2/2025Santiago ArroyoInsiderSell4,943$14.09$69,646.87 1/2/2025Travis Alvin ThompsonCAOSell1,750$14.09$24,657.50 12/16/2024Bros. Advisors Lp BakerDirectorBuy500,000$15.34$7,670,000.00 12/13/2024Bros. Advisors Lp BakerDirectorBuy985,397$13.76$13,559,062.72 11/11/2024Travis Alvin ThompsonCAOSell6,256$25.11$157,088.16 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/3/2024Kevin LeeCEOSell3,212$22.26$71,499.12 10/3/2024Michael Charles Ferguso HannayInsiderSell247$22.26$5,498.22 10/3/2024Michael SkynnerCTOSell972$22.26$21,636.72 10/3/2024Travis Alvin ThompsonCAOSell153$22.26$3,405.78 7/3/2024Kevin LeeCEOSell3,194$19.64$62,730.16 7/3/2024Michael Charles Ferguso HannayInsiderSell246$19.64$4,831.44 7/3/2024Michael SkynnerCTOSell967$19.64$18,991.88 7/3/2024Travis Alvin ThompsonCAOSell148$19.64$2,906.72 4/11/2024Michael Charles Ferguso HannayInsiderSell257$22.49$5,779.93 4/3/2024Kevin LeeCEOSell3,158$23.81$75,191.98 4/3/2024Michael SkynnerCTOSell955$23.81$22,738.55 4/3/2024Nicholas KeenInsiderSell790$23.81$18,809.90 4/3/2024Travis Alvin ThompsonCAOSell152$23.81$3,619.12 (Data available from 1/1/2013 forward) BCYC Insider Trading Activity - Frequently Asked Questions Who is on Bicycle Therapeutics's Insider Roster? The list of insiders at Bicycle Therapeutics includes Alethia Young, Alistair Milnes, Bros. Advisors Lp Baker, Kevin Lee, Lee Kalowski, Michael Charles Ferguso Hannay, Michael Skynner, Nicholas Keen, Nigel Crockett, Santiago Arroyo, and Travis Alvin Thompson. Learn more on insiders at BCYC. What percentage of Bicycle Therapeutics stock is owned by insiders? 8.50% of Bicycle Therapeutics stock is owned by insiders. Learn more on BCYC's insider holdings. Which Bicycle Therapeutics insiders have been buying company stock? The following insider purchased BCYC shares in the last 24 months: Bros. Advisors Lp Baker ($21,229,062.72). How much insider buying is happening at Bicycle Therapeutics? Insiders have purchased a total of 1,485,397 BCYC shares in the last 24 months for a total of $21,229,062.72 bought. Which Bicycle Therapeutics insiders have been selling company stock? The following insiders have sold BCYC shares in the last 24 months: Alethia Young ($19,655.55), Alistair Milnes ($73,344.02), Kevin Lee ($587,438.44), Lee Kalowski ($7,937.36), Michael Charles Ferguso Hannay ($16,109.59), Michael Skynner ($130,437.25), Nicholas Keen ($39,417.59), Nigel Crockett ($46,252.50), Santiago Arroyo ($69,646.87), and Travis Alvin Thompson ($245,148.38). How much insider selling is happening at Bicycle Therapeutics? Insiders have sold a total of 67,546 Bicycle Therapeutics shares in the last 24 months for a total of $1,235,387.55 sold. Bicycle Therapeutics Key ExecutivesDr. Kevin Lee M.B.A. (Age 56)Ph.D., CEO & Executive Director Compensation: $1.35MSir Gregory Paul Winter CBE (Age 73)FMedsci, FRS, HonFRCP, HonFTSE, Co-Founder & Non-Executive Director Compensation: $57.75kMs. Alethia Rene Young (Age 45)Chief Financial Officer Compensation: $581.69kDr. Santiago Arroyo M.D. (Age 64)Ph.D., Chief Development Officer Compensation: $916.98kDr. Christian HeinisScientific FounderMr. Alistair Milnes (Age 50)Chief Operating Officer Compensation: $796.09k1 recent tradesMr. Travis ThompsonSenior VP, Chief Accounting Officer & Principal Accounting Officer4 recent tradesDr. Michael Skynner B.sc. Ph.d. (Age 55)Ph.D., Chief Technology Officer Compensation: $881.01kDr. Nicholas Keen Ph.D. (Age 56)Chief Scientific Officer Mr. Zafar QadirGeneral Counsel More Insider Trading Tools from MarketBeat Related Companies Recursion Pharmaceuticals Insider Buying Xenon Pharmaceuticals Insider Buying Amneal Pharmaceuticals Insider Buying Catalyst Pharmaceuticals Insider Buying Bausch Health Companies Insider Buying NewAmsterdam Pharma Insider Buying Twist Bioscience Insider Buying Edgewise Therapeutics Insider Buying ImmunityBio Insider Buying MoonLake Immunotherapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:BCYC) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicycle Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
